+49 711 500 989 80
deen

Protein variant identified that renders chemotherapy ineffective in gastric cancer



Protein variant identified that renders chemotherapy ineffective in gastric cancer

A new protein variant underlies the ability of gastric cancers to resist an otherwise effective family of chemotherapy drugs, according to a study by a multidisciplinary team. The results suggest a treatment strategy that could improve the prognoses of many patients with cancer.

Materials provided by Weill Cornell Medicine. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

16th January 2022

MAPK4 emerges as a novel therapeutic target for triple-negative breast cancer

Read more
16th January 2022

Nuclei-free cells prove utility in delivering therapeutics to diseased tissues

Read more
15th January 2022

Blood test helps predict who may benefit from lung cancer screening

Read more